This activity is supported by an unrestricted educational grant from Bristol-Myers Squibb and Merck & Co.

Evolving Paradigms in Melanoma Therapy

Anthony J. Olszanski, MD, RPH,
Fox Chase Cancer Center

Brianna Hoffner, MS, ANP-BC, AOCNP
The Angeles Clinic and Research Institute

Learn the science behind immune response and treatment options for Melanoma. This activity provides an overview of differentiating checkpoint inhibitors from options such as kinase inhibitors, and cytotoxic chemotherapy.  Discuss potential toxicities, care management, and the AP role in the collaborative practice approach to patient care.



 

Download Podcast

  
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

  





These CE/CME/CEU accredited activities are jointly provided by

JADPRO Logo    Harborside Press Logo    APSHO Logo    Annenberg Logo
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here